organization · Reporting owner
Acuta Capital Fund, LP
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CAS MEDICAL SYSTEMS INCCASM · Entity 158232 | 10% owner | January 04, 2018 | May 01, 2018 |
| IRIDEX CORPIRIX · Entity 7882 | 10% owner | July 03, 2017 | May 01, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CAS MEDICAL SYSTEMS INC
Report date January 04, 2018 · Filed May 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,483,146 |
Ending reported balance
After 2018-03-19 transaction · row 22
22 source rows · reconciled sequenceRow 1 · 2017-12-27 · Purchase · Acquired 4,830 · Balance 3,433,513 F1: The shares were purchased in multiple transactions at prices ranging from $0.71 to $0.7298 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 2 · 2017-12-28 · Purchase · Acquired 1,380 · Balance 3,434,893 F2: The shares were purchased in multiple transactions at prices ranging from $0.6899 to $0.7049 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 3 · 2017-12-29 · Purchase · Acquired 8,896 · Balance 3,443,789 F3: The shares were purchased in multiple transactions at prices ranging from $0.70 to $0.77 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 4 · 2018-01-04 · Purchase · Acquired 5,440 · Balance 3,449,229 F4: The shares were purchased in multiple transactions at prices ranging from $0.85 to $0.86 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 5 · 2018-01-17 · Purchase · Acquired 100 · Balance 3,449,329 Row 6 · 2018-02-02 · Purchase · Acquired 1,000 · Balance 3,450,329 Row 7 · 2018-02-06 · Purchase · Acquired 2,811 · Balance 3,453,140 F5: The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.21 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 8 · 2018-02-09 · Purchase · Acquired 4,964 · Balance 3,458,104 F6: The shares were purchased in multiple transactions at prices ranging from $1.13 to $1.18 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 9 · 2018-02-12 · Purchase · Acquired 884 · Balance 3,458,988 F7: The shares were purchased in multiple transactions at prices ranging from $1.12 to $1.18 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 10 · 2018-02-13 · Purchase · Acquired 975 · Balance 3,459,963 F8: The shares were purchased in multiple transactions at prices ranging from $1.15 to $1.20 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 11 · 2018-02-16 · Purchase · Acquired 832 · Balance 3,460,795 F9: The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.17 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 12 · 2018-02-20 · Purchase · Acquired 2,290 · Balance 3,463,085 F10: The shares were purchased in multiple transactions at prices ranging from $1.10 to $1.16 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 13 · 2018-02-21 · Purchase · Acquired 300 · Balance 3,463,385 Row 14 · 2018-02-23 · Purchase · Acquired 333 · Balance 3,463,718 Row 15 · 2018-02-28 · Purchase · Acquired 2,720 · Balance 3,466,438 F11: The shares were purchased in multiple transactions at prices ranging from $1.14 to $1.15 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 16 · 2018-03-01 · Purchase · Acquired 1,814 · Balance 3,468,252 F12: The shares were purchased in multiple transactions at prices ranging from $1.06 to $1.08 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 17 · 2018-03-02 · Purchase · Acquired 680 · Balance 3,468,932 Row 18 · 2018-03-08 · Purchase · Acquired 400 · Balance 3,469,332 F13: The shares were purchased in multiple transactions at prices ranging from $1.09 to $1.12 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 19 · 2018-03-09 · Purchase · Acquired 1,180 · Balance 3,470,512 F14: The shares were purchased in multiple transactions at prices ranging from $1.06 to $1.10 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 20 · 2018-03-15 · Purchase · Acquired 9,370 · Balance 3,479,882 F15: The shares were purchased in multiple transactions at prices ranging from $1.05 to $1.21 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 21 · 2018-03-16 · Purchase · Acquired 2,176 · Balance 3,482,058 F16: The shares were purchased in multiple transactions at prices ranging from $1.22 to $1.26 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 22 · 2018-03-19 · Purchase · Acquired 1,088 · Balance 3,483,146 F17: The shares were purchased in multiple transactions at prices ranging from $1.22 to $1.28 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were purchased in multiple transactions at prices ranging from $0.71 to $0.7298 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: The shares were purchased in multiple transactions at prices ranging from $0.6899 to $0.7049 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: The shares were purchased in multiple transactions at prices ranging from $0.70 to $0.77 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: The shares were purchased in multiple transactions at prices ranging from $0.85 to $0.86 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5: The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.21 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6: The shares were purchased in multiple transactions at prices ranging from $1.13 to $1.18 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F7: The shares were purchased in multiple transactions at prices ranging from $1.12 to $1.18 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F8: The shares were purchased in multiple transactions at prices ranging from $1.15 to $1.20 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F9: The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.17 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F10: The shares were purchased in multiple transactions at prices ranging from $1.10 to $1.16 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F11: The shares were purchased in multiple transactions at prices ranging from $1.14 to $1.15 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F12: The shares were purchased in multiple transactions at prices ranging from $1.06 to $1.08 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F13: The shares were purchased in multiple transactions at prices ranging from $1.09 to $1.12 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F14: The shares were purchased in multiple transactions at prices ranging from $1.06 to $1.10 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F15: The shares were purchased in multiple transactions at prices ranging from $1.05 to $1.21 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F16: The shares were purchased in multiple transactions at prices ranging from $1.22 to $1.26 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F17: The shares were purchased in multiple transactions at prices ranging from $1.22 to $1.28 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
IRIDEX CORP
Report date July 03, 2017 · Filed May 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,344,720 |
Ending reported balance
After 2017-08-25 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2017-08-16 · Purchase · Acquired 2,260 · Balance 1,343,984 F1: The shares were purchased in multiple transactions at prices ranging from $8.38 to $8.47 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 2 · 2017-08-22 · Purchase · Acquired 500 · Balance 1,344,484 F2: The shares were purchased in multiple transactions at prices ranging from $8.41 to $8.44 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 3 · 2017-08-25 · Purchase · Acquired 236 · Balance 1,344,720 F3: The shares were purchased in multiple transactions at prices ranging from $8.66 to $8.67 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were purchased in multiple transactions at prices ranging from $8.38 to $8.47 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: The shares were purchased in multiple transactions at prices ranging from $8.41 to $8.44 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: The shares were purchased in multiple transactions at prices ranging from $8.66 to $8.67 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 29, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 25,519 | $1.18 | $30,035.86 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 15 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,140,275 F15 · price: The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.21 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 28, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 17,643 | $1.18 | $20,783.45 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 14 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,114,756 F14 · price: The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.20 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 27, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 7,595 | $1.17 | $8,909.69 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 13 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,097,113 F13 · price: The shares were purchased in multiple transactions at prices ranging from $1.14 to $1.195 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 26, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 28,476 | $1.14 | $32,431.32 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 12 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,089,518 F12 · price: The shares were purchased in multiple transactions at prices ranging from $1.11 to $1.15 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 23, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 21,142 | $1.14 | $24,095.54 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 11 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,061,042 F11 · price: The shares were purchased in multiple transactions at prices ranging from $1.11 to $1.17 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 22, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 25,551 | $1.09 | $27,963.01 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 10 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,039,900 F10 · price: The shares were purchased in multiple transactions at prices ranging from $1.06 to $1.13 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 21, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 41,540 | $1.04 | $43,284.68 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 9 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,014,349 F9 · price: The shares were purchased in multiple transactions at prices ranging from $1.02 to $1.06 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 20, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 37,520 | $1.01 | $37,805.15 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 8 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,972,809 F8 · price: The shares were purchased in multiple transactions at prices ranging from $0.992 to $1.06 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 17, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 16,853 | $1.50 | $25,227.26 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 7 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,935,289 F7 · price: The shares were purchased in multiple transactions at prices ranging from $1.46 to $1.53 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 16, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,010 | $1.49 | $2,988.07 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 6 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,918,436 F6 · price: The shares were purchased in multiple transactions at prices ranging from $1.48 to $1.50 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,632 | $1.52 | $2,485.86 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 5 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,916,426 F5 · price: The shares were purchased in multiple transactions at prices ranging from $1.51 to $1.54 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 13, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 3,292 | $1.47 | $4,827.39 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 4 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,914,764 F4 · price: The shares were purchased in multiple transactions at prices ranging from $1.45 to $1.49 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 10, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 895 | $1.50 | $1,343.22 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 3 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,911,502 F3 · price: The shares were purchased in multiple transactions at prices ranging from $1.50 to $1.51 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 09, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 7,490 | $1.48 | $11,115.16 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 2 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,910,607 F2 · price: The shares were purchased in multiple transactions at prices ranging from $1.45 to $1.51 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 08, 2017 Filed May 1, 2018 17:12 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,340 | $1.44 | $1,935.63 |
DisclosureSEC source: 0001209191-18-027152 · doc4.xml · nonDerivative · entry 1 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,903,117 F1 · price: The shares were purchased in multiple transactions at prices ranging from $1.44 to $1.45 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 07, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 4,020 | $1.45 | $5,820.16 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 30 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,901,777 F26 · price: The shares were purchased in multiple transactions at prices ranging from $1.44 to $1.45 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 01, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 23,306 | $1.48 | $34,492.88 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 29 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,897,757 Read SEC document |
| February 28, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,639 | $1.49 | $2,440.63 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 28 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,874,451 F25 · price: The shares were purchased in multiple transactions at prices ranging from $1.48 to $1.51 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,010 | $1.50 | $3,006.56 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 27 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,872,812 F24 · price: The shares were purchased in multiple transactions at prices ranging from $1.48 to $1.50 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 24, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,340 | $1.49 | $1,996.60 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 26 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,870,802 Read SEC document |
| February 23, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,680 | $1.47 | $3,926.20 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 25 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,869,462 F23 · price: The shares were purchased in multiple transactions at prices ranging from $1.46 to $1.48 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 22, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 4,020 | $1.49 | $6,003.07 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 24 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,866,782 F22 · price: The shares were purchased in multiple transactions at prices ranging from $1.48 to $1.50 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 21, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 670 | $1.50 | $1,001.65 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 23 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,862,762 F21 · price: The shares were purchased in multiple transactions at prices ranging from $1.49 to $1.50 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 15, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,340 | $1.51 | $2,022.73 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 22 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,862,092 F20 · price: The shares were purchased in multiple transactions at prices ranging from $1.50 to $1.52 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 13, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 670 | $1.50 | $1,005.00 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 21 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860,752 Read SEC document |
| February 10, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,675 | $1.50 | $2,511.66 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 20 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860,082 F19 · price: The shares were purchased in multiple transactions at prices ranging from $1.49 to $1.50 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 08, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 895 | $1.53 | $1,364.88 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 19 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,858,407 F18 · price: The shares were purchased in multiple transactions at prices ranging from $1.52 to $1.54 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 07, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,010 | $1.51 | $3,040.53 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 18 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,857,512 F17 · price: The shares were purchased in multiple transactions at prices ranging from $1.50 to $1.52 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 670 | $1.53 | $1,025.10 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 17 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,855,502 Read SEC document |
| February 03, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 15,798 | $1.53 | $24,188.32 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 16 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,854,832 F16 · price: The shares were purchased in multiple transactions at prices ranging from $1.51 to $1.56 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 02, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,876 | $1.55 | $2,909.11 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 15 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,839,034 F15 · price: The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.56 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 31, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,452 | $1.52 | $2,212.99 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 14 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,837,158 F14 · price: The shares were purchased in multiple transactions at prices ranging from $1.49 to $1.54 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 30, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,706 | $1.51 | $4,098.51 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 13 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,835,706 F13 · price: The shares were purchased in multiple transactions at prices ranging from $1.51 to $1.52 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 27, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 2,640 | $1.51 | $3,992.74 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 12 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,833,000 F12 · price: The shares were purchased in multiple transactions at prices ranging from $1.49 to $1.54 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 20, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 5,676 | $1.55 | $8,782.47 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 11 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,830,360 F11 · price: The shares were purchased in multiple transactions at prices ranging from $1.54 to $1.57 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 19, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 38,940 | $1.60 | $62,296.21 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 10 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,824,684 F10 · price: The shares were purchased in multiple transactions at prices ranging from $1.59 to $1.60 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 18, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 10,829 | $1.69 | $18,262.03 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 9 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,785,744 F9 · price: The shares were purchased in multiple transactions at prices ranging from $1.65 to $1.73 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 17, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 1,015 | $1.72 | $1,744.38 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 8 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,774,915 F8 · price: The shares were purchased in multiple transactions at prices ranging from $1.70 to $1.72 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 13, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 3,170 | $1.72 | $5,436.55 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 7 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,773,900 F7 · price: The shares were purchased in multiple transactions at prices ranging from $1.69 to $1.72 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 11, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 8,118 | $1.65 | $13,417.43 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 6 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,770,730 F6 · price: The shares were purchased in multiple transactions at prices ranging from $1.63 to $1.68 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 10, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 3,360 | $1.61 | $5,426.06 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 5 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,762,612 F5 · price: The shares were purchased in multiple transactions at prices ranging from $1.60 to $1.62 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 09, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 3,366 | $1.63 | $5,493.99 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 4 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,759,252 F4 · price: The shares were purchased in multiple transactions at prices ranging from $1.63 to $1.64 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 06, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 4,068 | $1.62 | $6,570.23 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 3 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,755,886 F3 · price: The shares were purchased in multiple transactions at prices ranging from $1.605 to $1.63 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 05, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 411 | $1.61 | $660.93 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 2 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,751,818 F2 · price: The shares were purchased in multiple transactions at prices ranging from $1.60 to $1.63 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2017 Filed May 1, 2018 17:11 UTC | CAS MEDICAL SYSTEMS INC CASM · Entity 158232 | PurchaseCommon Stock | 858 | $1.60 | $1,368.51 |
DisclosureSEC source: 0001209191-18-027151 · doc4.xml · nonDerivative · entry 1 Acuta Capital Fund, LP · CIK 0001601391 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,751,407 F1 · price: The shares were purchased in multiple transactions at prices ranging from $1.58 to $1.60 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.